ARIXTRA INJECTION 7.5mg/0.6ml syr (Fondaparinux Sodium)

ARIXTRA INJECTION (Fondaparinux Sodium) is a synthetic anticoagulant that plays a crucial role in the prevention and treatment of various thromboembolic disorders. This medication is particularly effective in preventing deep vein thrombosis (DVT) and pulmonary embolism (PE) in patients undergoing surgeries such as hip or knee replacement.

Key highlights of ARIXTRA include:

• Mechanism of Action: Fondaparinux works by inhibiting Factor Xa, an essential component in the blood coagulation cascade, thereby preventing the formation of blood clots.


• Administration: The injection is administered subcutaneously, making it convenient for both healthcare providers and patients. It is typically given once daily.


• Indications: ARIXTRA is indicated for the prevention of venous thromboembolism in patients undergoing surgery and for the treatment of acute DVT and PE.


• Safety Profile: While generally well tolerated, it is important to monitor for potential side effects such as bleeding, which is a common risk associated with anticoagulants.


• Contraindications: Patients with a history of severe renal impairment or active bleeding should avoid this medication.


• Patient Education: It is essential for patients to understand the importance of adhering to the prescribed dosage and to recognize signs of bleeding or other adverse effects.

Overall, ARIXTRA is a valuable addition to anticoagulation therapy, providing effective prevention and treatment options for patients at risk of thromboembolic events.

• Fondaparinux Sodium


• Water for Injection


• Sodium Chloride


• Hydrochloric Acid


• Sodium Hydroxide

ARIXTRA INJECTION (Fondaparinux Sodium) is an anticoagulant medication used to prevent blood clots. To ensure the safe and effective use of this product, follow these detailed instructions.

1. 
   

   Before using ARIXTRA, wash your hands thoroughly with soap and water to prevent any contamination.

   
   


2. 
   

   Gather all necessary supplies, including the ARIXTRA injection, an alcohol swab, and a sharps disposal container.

   
   


3. 
   

   Check the medication vial for any visible particles or discoloration. Do not use the injection if it appears cloudy or has any particles.

   
   


4. 
   

   Remove the cap from the syringe, being careful not to touch the needle. If the syringe has a safety device, ensure it is functioning properly before use.

   
   


5. 
   

   Choose an injection site, typically the fatty tissue of the abdomen or thigh, avoiding areas with scars, bruises, or blemishes.

   
   


6. 
   

   Clean the injection site with an alcohol swab and allow it to dry completely to minimize discomfort during the injection.

   
   


7. 
   

   Pinch the skin around the injection site to create a fold. Hold the syringe like a pencil and insert the needle at a 90-degree angle to the skin.

   
   


8. 
   

   Inject the medication slowly and steadily. Once the injection is complete, withdraw the needle quickly at the same angle.

   
   


9. 
   

   Apply gentle pressure to the injection site with a cotton ball or gauze to minimize bleeding. Do not rub the area.

   
   


10. 
    

    Dispose of the used syringe and needle in a sharps disposal container immediately after use to prevent needle-stick injuries.

    
    


11. 
    

    Wash your hands again after disposing of the injection materials.

    
    


12. 
    

    Follow your healthcare provider's instructions regarding the dosage and frequency of injections. Do not exceed the recommended dose.

    
    

If you experience any unusual side effects or signs of an allergic reaction, contact your healthcare provider immediately. Always keep ARIXTRA out of reach of children and store it at room temperature, away from moisture and heat.